According to Future Market Insights (FMI), the global biosimulation market is expected to witness remarkable growth, driven by increasing investments in pharmaceutical R&D, growing adoption of computational modeling in drug development, rising demand for precision medicine, and expanding use of artificial intelligence in life sciences. The integration of biosimulation platforms across drug...